ATE205482T1 - Sulfonamide derivate und verfahren zu deren herstellung - Google Patents
Sulfonamide derivate und verfahren zu deren herstellungInfo
- Publication number
- ATE205482T1 ATE205482T1 AT96107694T AT96107694T ATE205482T1 AT E205482 T1 ATE205482 T1 AT E205482T1 AT 96107694 T AT96107694 T AT 96107694T AT 96107694 T AT96107694 T AT 96107694T AT E205482 T1 ATE205482 T1 AT E205482T1
- Authority
- AT
- Austria
- Prior art keywords
- substituted
- unsubstituted
- sub
- hypertension
- sup
- Prior art date
Links
- 229940124530 sulfonamide Drugs 0.000 title abstract 2
- 150000003456 sulfonamides Chemical class 0.000 title abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 239000004215 Carbon black (E152) Substances 0.000 abstract 1
- 206010007558 Cardiac failure chronic Diseases 0.000 abstract 1
- 102000002045 Endothelin Human genes 0.000 abstract 1
- 108050009340 Endothelin Proteins 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- -1 R<sup>1</sup> is H Chemical group 0.000 abstract 1
- 208000003782 Raynaud disease Diseases 0.000 abstract 1
- 208000012322 Raynaud phenomenon Diseases 0.000 abstract 1
- 208000007107 Stomach Ulcer Diseases 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004450 alkenylene group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 125000002619 bicyclic group Chemical group 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 abstract 1
- 201000005917 gastric ulcer Diseases 0.000 abstract 1
- 229930195733 hydrocarbon Natural products 0.000 abstract 1
- 150000002430 hydrocarbons Chemical class 0.000 abstract 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 208000002815 pulmonary hypertension Diseases 0.000 abstract 1
- 206010038464 renal hypertension Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/69—Benzenesulfonamido-pyrimidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7116213A JP3013752B2 (ja) | 1995-05-16 | 1995-05-16 | スルホンアミド誘導体 |
| JP14987295 | 1995-06-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE205482T1 true ATE205482T1 (de) | 2001-09-15 |
Family
ID=26454593
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99110998T ATE224879T1 (de) | 1995-05-16 | 1996-05-14 | Sulfonamide derivate und verfahren zu deren herstellung |
| AT96107694T ATE205482T1 (de) | 1995-05-16 | 1996-05-14 | Sulfonamide derivate und verfahren zu deren herstellung |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99110998T ATE224879T1 (de) | 1995-05-16 | 1996-05-14 | Sulfonamide derivate und verfahren zu deren herstellung |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5739333A (de) |
| EP (3) | EP0959073A1 (de) |
| KR (1) | KR100411358B1 (de) |
| CN (1) | CN1100043C (de) |
| AT (2) | ATE224879T1 (de) |
| CA (1) | CA2176776A1 (de) |
| DE (2) | DE69624010T2 (de) |
| DK (2) | DK0743307T3 (de) |
| ES (2) | ES2184367T3 (de) |
| GR (1) | GR3036611T3 (de) |
| MX (2) | MX9601837A (de) |
| PT (2) | PT743307E (de) |
| TW (1) | TW350839B (de) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5739333A (en) * | 1995-05-16 | 1998-04-14 | Tanabe Seiyaku Co., Ltd. | Sulfonamide derivative and process for preparing the same |
| US7045519B2 (en) | 1998-06-19 | 2006-05-16 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
| US6417185B1 (en) | 1998-06-19 | 2002-07-09 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
| CA2315614C (en) | 1999-07-29 | 2004-11-02 | Pfizer Inc. | Pyrazoles |
| ES2295048T3 (es) * | 1999-09-03 | 2008-04-16 | Actelion Pharmaceuticals Ltd. | Bis-sulfonamidas. |
| US6720322B2 (en) | 1999-12-22 | 2004-04-13 | Actelion Pharamceuticals Ltd. | Butyne diol derivatives |
| CA2389479A1 (en) * | 1999-12-22 | 2001-06-28 | Christoph Boss | Butyne diol derivatives |
| DE60025803T2 (de) * | 2000-01-25 | 2006-11-02 | F. Hoffmann-La Roche Ag | Herstellung von sulfonamiden |
| US6387915B2 (en) | 2000-05-31 | 2002-05-14 | Pfizer Inc. | Isoxazole-sulfonamide endothelin antagonists |
| HUP0300649A3 (en) * | 2000-06-13 | 2003-10-28 | Basf Ag | Fungicidal 5-phenyl substituted 2-(cyanoamino)pyrimidines, preparation and use thereof |
| MY140724A (en) | 2000-07-21 | 2010-01-15 | Actelion Pharmaceuticals Ltd | Novel arylethene-sulfonamides |
| US6670362B2 (en) | 2000-09-20 | 2003-12-30 | Pfizer Inc. | Pyridazine endothelin antagonists |
| NZ524172A (en) | 2000-09-25 | 2004-09-24 | Actelion Pharmaceuticals Ltd | Arylalkane-sulfonamides useful as endothelin receptor antagonists |
| WO2002053557A1 (en) * | 2000-12-18 | 2002-07-11 | Actelion Pharmaceuticals Ltd | Novel sulfamides and their use as endothelin receptor antagonists |
| CN100488952C (zh) * | 2001-03-15 | 2009-05-20 | 巴斯福股份公司 | 5-苯基嘧啶、其制备方法和中间体产物及其在防治有害真菌中的用途 |
| US7323465B2 (en) * | 2002-01-02 | 2008-01-29 | Actelion Pharmaceuticals Ltd. | Alkansulfonamides as endothelin antagonists |
| EP2399903A1 (de) | 2002-05-24 | 2011-12-28 | Millennium Pharmaceuticals, Inc. | CCR9-Hemmer und Verwendungsverfahren dafür |
| EP1569914B1 (de) | 2002-12-02 | 2009-02-18 | Actelion Pharmaceuticals Ltd. | Pyrimidin-sulfonamide und ihre verwendung als endothelin-rezeptor-antagonisten |
| ES2391636T3 (es) | 2004-03-05 | 2012-11-28 | F. Hoffmann-La Roche Ag | Diaminopirimidinas como antagonistas de P2X3 y P2X2/3 |
| DE102004044829A1 (de) * | 2004-09-16 | 2006-04-06 | Bayer Cropscience Ag | 5-Heterocyclylpyrimidine |
| TW200628467A (en) | 2004-11-11 | 2006-08-16 | Actelion Pharmaceuticals Ltd | Novel sulfamides |
| WO2007025901A1 (en) | 2005-09-01 | 2007-03-08 | F. Hoffmann-La Roche Ag | Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| ES2612890T3 (es) | 2005-09-01 | 2017-05-19 | F. Hoffmann-La Roche Ag | Diaminopirimidinas como moduladores de P2X3 y P2X2/3 |
| JP4850912B2 (ja) | 2005-09-01 | 2012-01-11 | エフ．ホフマン−ラ ロシュ アーゲー | Ｐ２ｘ３およびｐ３ｘ２／３モジュレーターとしてのジアミノピリミジン |
| US20100022568A1 (en) * | 2006-04-13 | 2010-01-28 | Actelion Pharmaceeuticals Ltd. | Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis |
| AR062501A1 (es) | 2006-08-29 | 2008-11-12 | Actelion Pharmaceuticals Ltd | Composiciones terapeuticas |
| WO2009004374A1 (en) * | 2007-06-29 | 2009-01-08 | Generics [Uk] Limited | Process for introduction of hydroxyethoxy side chain in bosentan |
| MX2010001837A (es) | 2007-08-17 | 2010-03-10 | Actelion Pharmaceuticals Ltd | Derivados de 4-pirimidinasulfamida. |
| JP2011500780A (ja) * | 2007-10-24 | 2011-01-06 | ジェネリクス・（ユーケー）・リミテッド | 新規結晶形 |
| EP2072503B1 (de) * | 2007-12-18 | 2011-10-26 | Dipharma Francis S.r.l. | Verfahren zur Herstellung von Bosentan |
| US8785461B2 (en) * | 2008-02-08 | 2014-07-22 | Generics [Uk] Limited | Process for preparing bosentan |
| WO2009112954A2 (en) * | 2008-03-13 | 2009-09-17 | Actavis Group Ptc Ehf | Processes for the preparation of bosentan and related compounds using novel intermediates |
| EP2350028A1 (de) | 2008-11-03 | 2011-08-03 | Generics [UK] Limited | Hplc-methode zur analyse von bosentan und verwandten substanzen und die verwendung dieser substanzen als referenzstandards und marker |
| WO2012056468A1 (en) * | 2010-10-13 | 2012-05-03 | Matrix Laboratories Ltd | A process for the preparation of bosentan |
| CN104892528A (zh) * | 2014-12-10 | 2015-09-09 | 上海工程技术大学 | 一种2-硫代巴比妥酸衍生物的制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1545944A1 (de) * | 1964-06-19 | 1969-12-11 | Hoffmann La Roche | Verfahren zur Herstellung von neuen Sulfonamiden der Pyrimidinreihe |
| ATE20064T1 (de) * | 1982-07-22 | 1986-06-15 | Pfizer | Anti-ischaemische und antihypertensive dihydropyridin-derivate. |
| KR920009574B1 (ko) * | 1990-02-02 | 1992-10-19 | 재단법인 한국화학연구소 | 페닐아세트아미드 유도체 및 그의 제조방법 |
| TW270116B (de) * | 1991-04-25 | 1996-02-11 | Hoffmann La Roche | |
| RU2086544C1 (ru) * | 1991-06-13 | 1997-08-10 | Хоффманн-Ля Рош АГ | Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина |
| NZ247440A (en) * | 1992-05-06 | 1995-04-27 | Squibb & Sons Inc | Phenyl sulphonamide derivatives, preparation and pharmaceutical compositions thereof |
| TW287160B (de) * | 1992-12-10 | 1996-10-01 | Hoffmann La Roche | |
| TW394761B (en) * | 1993-06-28 | 2000-06-21 | Hoffmann La Roche | Novel Sulfonylamino Pyrimidines |
| IL111959A (en) * | 1993-12-17 | 2000-07-16 | Tanabe Seiyaku Co | N-(polysubstituted pyrimidin-4-yl) benzenesulfonamide derivatives their preparation and pharmaceutical compositions containing them |
| US5739333A (en) * | 1995-05-16 | 1998-04-14 | Tanabe Seiyaku Co., Ltd. | Sulfonamide derivative and process for preparing the same |
| WO1998000288A1 (en) * | 1996-06-28 | 1998-01-08 | Ranpak Corp. | Cushioning conversion machine |
-
1996
- 1996-05-09 US US08/644,847 patent/US5739333A/en not_active Expired - Fee Related
- 1996-05-14 ES ES99110998T patent/ES2184367T3/es not_active Expired - Lifetime
- 1996-05-14 DK DK96107694T patent/DK0743307T3/da active
- 1996-05-14 PT PT96107694T patent/PT743307E/pt unknown
- 1996-05-14 ES ES96107694T patent/ES2163548T3/es not_active Expired - Lifetime
- 1996-05-14 EP EP99110999A patent/EP0959073A1/de not_active Withdrawn
- 1996-05-14 AT AT99110998T patent/ATE224879T1/de not_active IP Right Cessation
- 1996-05-14 EP EP99110998A patent/EP0959072B1/de not_active Expired - Lifetime
- 1996-05-14 AT AT96107694T patent/ATE205482T1/de not_active IP Right Cessation
- 1996-05-14 DK DK99110998T patent/DK0959072T3/da active
- 1996-05-14 DE DE69624010T patent/DE69624010T2/de not_active Expired - Fee Related
- 1996-05-14 DE DE69615085T patent/DE69615085T2/de not_active Expired - Fee Related
- 1996-05-14 PT PT99110998T patent/PT959072E/pt unknown
- 1996-05-14 EP EP96107694A patent/EP0743307B1/de not_active Expired - Lifetime
- 1996-05-15 MX MX9601837A patent/MX9601837A/es not_active IP Right Cessation
- 1996-05-16 KR KR1019960016486A patent/KR100411358B1/ko not_active Expired - Fee Related
- 1996-05-16 CA CA002176776A patent/CA2176776A1/en not_active Abandoned
- 1996-05-16 CN CN96106284A patent/CN1100043C/zh not_active Expired - Fee Related
- 1996-05-22 TW TW085106047A patent/TW350839B/zh active
-
2000
- 2000-11-10 MX MXPA00011111A patent/MXPA00011111A/es unknown
-
2001
- 2001-09-13 GR GR20010400308T patent/GR3036611T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69615085D1 (de) | 2001-10-18 |
| CN1100043C (zh) | 2003-01-29 |
| DE69624010T2 (de) | 2003-05-22 |
| CA2176776A1 (en) | 1996-11-17 |
| GR3036611T3 (en) | 2001-12-31 |
| ES2163548T3 (es) | 2002-02-01 |
| MXPA00011111A (es) | 2003-04-25 |
| ES2184367T3 (es) | 2003-04-01 |
| ATE224879T1 (de) | 2002-10-15 |
| DK0743307T3 (da) | 2001-11-26 |
| US5739333A (en) | 1998-04-14 |
| KR960041179A (ko) | 1996-12-19 |
| DK0959072T3 (da) | 2003-01-20 |
| TW350839B (en) | 1999-01-21 |
| DE69615085T2 (de) | 2002-06-06 |
| CN1146990A (zh) | 1997-04-09 |
| KR100411358B1 (ko) | 2004-07-05 |
| EP0743307A1 (de) | 1996-11-20 |
| PT959072E (pt) | 2002-12-31 |
| PT743307E (pt) | 2001-12-28 |
| MX9601837A (es) | 1997-07-31 |
| EP0959072A1 (de) | 1999-11-24 |
| EP0959073A1 (de) | 1999-11-24 |
| EP0743307B1 (de) | 2001-09-12 |
| EP0959072B1 (de) | 2002-09-25 |
| DE69624010D1 (de) | 2002-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE224879T1 (de) | Sulfonamide derivate und verfahren zu deren herstellung | |
| NO20013369L (no) | Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon | |
| WO1999024022A3 (en) | Isoquinoline derivatives for treating disorders associated with 5ht7 receptors | |
| ATE334975T1 (de) | Sulfonamidderivate, ihre herstellung und verwendung | |
| NL300006I1 (nl) | Imidazolylalkeenzuurderivaten. | |
| UA66825C2 (uk) | Азаполіциклічні сполуки, конденсовані з арилом, фармацевтична композиція, спосіб лікування та спосіб зниження нікотинової залежності | |
| KR890009937A (ko) | 치환된 티에노이미다졸 유도체, 이의 제조방법, 이를 함유한 약제 조성물, 및 위산분비 억제제로서의 이의 용도 | |
| CA2124680A1 (en) | Piperazine derivatives as 5-ht1a antagonists | |
| EA199800908A1 (ru) | Производные индола, полезные в качестве антагонистов рецептора эндотелина | |
| EA200100042A1 (ru) | Бензимидазолы, их получение и их применение в качестве лекарственных средств | |
| ATE139233T1 (de) | Annelierte thiophen-derivate, ihre herstellung und verwendung | |
| NZ514487A (en) | Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands | |
| KR900009598A (ko) | 혈관평활근 이완작용을 가진 화합물과 그의 제조방법 | |
| DE69819173D1 (de) | Indole und 2,3-dihydroindolderivate, ihre herstellung und verwendung | |
| ATE266017T1 (de) | Radicicolderivate | |
| DE69313051D1 (de) | Ethanolamin-derivate mit sympathomimetischer und anti-pollakiuria wirkung | |
| ATE70063T1 (de) | Dihydrobenzofuran- und chromancarboxamidderivate, verfahren zu ihrer herstellung und ihre verwendung als neuroleptica. | |
| CA2134077A1 (en) | 4-imidomethyl-1-[2'phenyl-2'oxoethyl-]piperidines as serotonin 5ht2-antagonists, their preparation and use in therapy | |
| ATE121395T1 (de) | Cumarinderivate, ihre herstellung und ihre verwendung zur behandlung von zerebrovaskulären störungen. | |
| PT1430047E (pt) | Derivados de alquilaminopiridazinona substituida, processo para a sua preparacao e composicoes farmaceuticas que os contem | |
| DE69514532D1 (de) | Indol-2,3-dione-3-oximderivate, ihre herstellung und verwendung | |
| ATE281460T1 (de) | Pyrido-1,2,4-thiadiazine und pyrido-1-4- thiazinderivate, ihre herstellung und ihre verwendung | |
| EP0229944A3 (de) | Tetrahydroisochinolinderivate | |
| EP0701551A1 (de) | 3-(INDOL-3-YL) PROPENSäURDERIVATE ALS NMDA- ANTAGONISTEN | |
| ATE58135T1 (de) | 1,3-oxathianderivate. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REN | Ceased due to non-payment of the annual fee |